Latest news
OTLK Stock Surges On FDA Lytenava Application Resubmission After Successful Appeal - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 22:28:56 GMTOTLK Stock Rocket Nearly 140%: FDA's Lytenava FDR Approval Pushes Stock On Track For Best Week On Record - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 01:43:58 GMTOutlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026 - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 13:04:49 GMTOutlook Therapeutics Stock (OTLK) Opinions on FDA Approval of LYTENAVA - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 14:05:00 GMTOTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision - stocktwits.comstocktwits.com · Wed, 05 Aug 2026 02:01:08 GMTRetina specialists weigh in on FDA approval of bevacizumab-vikg (Lytenava) for wet AMD - Ophthalmology Times EuropeOphthalmology Times Europe · Sun, 02 Aug 2026 19:01:11 GMTOutlook: 'Hold' - Caution On LYTENAVA FDA Approval And Cash Needs (NASDAQ:OTLK) - Seeking AlphaSeeking Alpha · Tue, 28 Jul 2026 07:00:00 GMTFDA approves Outlook's LYTENAVA for wet AMD - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Mon, 27 Jul 2026 18:59:58 GMT